The transcription factor ATF4 promotes skeletal myofiber atrophy during fasting

Molecular Endocrinology

Volumn 24, Issue 4, 2010, Pages 790-799

  Ebert, Scott M ^b   Monteys, Alex Mas ^b   Fox, Daniel K ^b   Bongers, Kale S ^b   Shields, Bridget E ^b   Malmberg, Sharon E ^b   Davidson, Beverly L ^b   Suneja, Manish ^b   Adams, Christopher M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ANKYRIN; CARDIAC ANKYRIN REPEAT PROTEIN; CONNECTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; INITIATION FACTOR 2ALPHA; LIM PROTEIN; MESSENGER RNA; MUSCLE LIM PROTEIN; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PEG3; TRANSCRIPTION FACTOR PW1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SIZE; CONTROLLED STUDY; DIET RESTRICTION; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH INHIBITION; MALE; MEDIATOR; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; FASTING; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCULAR ATROPHY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EUKARYOTA;

EID: 77950430489     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0345     Document Type: Article

References (55)

1. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, Ron D 2003 An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11:619-633
2. Yamaguchi S, Ishihara H, Yamada T, Tamura A, Usui M, Tominaga R, Munakata Y, Satake C, Katagiri H, Tashiro F, Aburatani H, Tsukiyama-Kohara K, Miyazaki J, Sonenberg N, Oka Y 2008 ATF4-mediated induction of 4E-BP1 contributes to pancreatic β-cell survival under endoplasmic reticulum stress. Cell Metab 7:269-276
3. Wek RC, Cavener DR 2007 Translational control and the unfolded protein response. Antioxid Redox Signal 9:2357-2371
4. Proud CG 2005 eIF2 and the control of cell physiology. Semin Cell Dev Biol 16:3-12
5. Kaufman RJ, Davies MV, Pathak VK, Hershey JW 1989 The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol Cell Biol 9:946-958
6. Pathak VK, Schindler D, Hershey JW 1988 Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases. Mol Cell Biol 8:993-995
7. Siu F, Bain PJ, LeBlanc-Chaffin R, Chen H, Kilberg MS 2002 ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J Biol Chem 277:24120-24127
8. Hinnebusch AG 2005 Translational regulation of GCN4 and the general amino acid control of yeast. Annu Rev Microbiol 59:407-450
9. Hammarqvist F, Andersson K, Luo JL, Wernerman J 2005 Free amino acid and glutathione concentrations in muscle during short-term starvation and refeeding. Clin Nutr 24:236-243
10. Yuan CL, Sharma N, Gilge DA, Stanley WC, Li Y, Hatzoglou M, Previs SF 2008 Preserved protein synthesis in the heart in response to acute fasting and chronic food restriction despite reductions in liver and skeletal muscle. Am J Physiol Endocrinol Metab 295:E216-E222
11. Jagoe RT, Lecker SH, Gomes M, Goldberg AL 2002 Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J 16:1697-1712
12. Sandri M 2008 Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23:160-170
13. Adams CM 2007 Role of the transcription factor ATF4 in the anabolic actions of insulin and the anti-anabolic actions of glucocorticoids. J Biol Chem 282:16744-16753
14. Boudreau RL, Monteys AM, Davidson BL 2008 Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. RNA 14:1834-1844
15. Alzghoul MB, Gerrard D, Watkins BA, Hannon K 2004 Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J 18:221-223
16. Rana ZA, Ekmark M, Gundersen K 2004 Coexpression after electroporation of plasmid mixtures into muscle in vivo. Acta Physiol Scand 181:233-238
17. Judge AR, Koncarevic A, Hunter RB, Liou HC, Jackman RW, Kandarian SC 2007 Role for IκBα, but not c-Rel, in skeletal muscle atrophy. Am J Physiol 292:C372-382
18. Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, Edgerton VR, Lecker SH, Goldberg AL 2007 Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21:140-155
19. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ 2001 Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708
20. Perkins DJ, Barber GN 2004 Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts. Mol Cell Biol 24:2025-2040
21. He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM, Alam J 2001 Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem 276:20858-20865
22. Hai T, Hartman MG 2001 The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273:1-11
23. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, Tintignac LA, Segura CT, Leibovitch SA 2008 The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 27:1266-1276
24. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E, Glass DJ 2007 The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 6:376-385
25. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA 2009 Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PloS One 4:e4973
26. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL 2009 During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185:1083-1095
27. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
28. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
29. Rosemary Siafakas A, Richardson DR 2009 Growth arrest and DNA damage-45α (GADD45α). Int J Biochem Cell Biol 41:986-989
30. Schwarzkopf M, Coletti D, Sassoon D, Marazzi G 2006 Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev 20:3440-3452
31. Granzier HL, Labeit S 2004 The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ Res 94:284-295
32. Arber S, Halder G, Caroni P 1994 Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79:221-231
33. Zou Y, Evans S, Chen J, Kuo HC, Harvey RP, Chien KR 1997 CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development 124:793-804
34. Knöll R, Hoshijima M, Hoffman HM, Person V, Lorenzen-Schmidt I, Bang ML, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W, Yokoyama M, Schork NJ, Omens JH, McCulloch AD, Kimura A, Gregorio CC, Poller W, Schaper J, Schultheiss HP, Chien KR 2002 The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111:943-955
35. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC, Labeit S 2003 The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol 333:951-964
36. Papalouka V, Arvanitis DA, Vafiadaki E, Mavroidis M, Papadodima SA, Spiliopoulou CA, Kremastinos DT, Kranias EG, Sanoudou D 2009 Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and skeletal muscle. Mol Cell Biol 29:6046-6058
37. Eley HL, Skipworth RJ, Deans DA, Fearon KC, Tisdale MJ 2008 Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients. Br J Cancer 98:443-449
38. Laure L, Suel L, Roudaut C, Bourg N, Ouali A, Bartoli M, Richard I, Danièle N 2009 Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling. FEBS J 276:669-684
39. Zeman RJ, Zhao J, Zhang Y, Zhao W, Wen X, Wu Y, Pan J, Bauman WA, Cardozo C 2009 Differential skeletal muscle gene expression after upper or lower motor neuron transection. Pflugers Arch 458:525-535
40. Lehti TM, Silvennoinen M, KiveläR, Kainulainen H, Komulainen J 2007 Effects of streptozotocin-induced diabetes and physical training on gene expression of titin-based stretch-sensing complexes in mouse striated muscle. Am J Physiol Endocrinol Metab 292:E533-E542
41. Edwards MG, Anderson RM, Yuan M, Kendziorski CM, Weindruch R, Prolla TA 2007 Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics 8:80
42. Welle S, Brooks AI, Delehanty JM, Needler N, Thornton CA 2003 Gene expression profile of aging in human muscle. Physiol Genomics 14:149-159
43. Welle S, Brooks AI, Delehanty JM, Needler N, Bhatt K, Shah B, Thornton CA 2004 Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women. Exp Gerontol 39:369-377
44. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, Sandri M 2009 Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296:C1248-C1257
45. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL 2004 Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412
46. Van Gammeren D, Damrauer JS, Jackman RW, Kandarian SC 2009 The IκB kinases IKKα and IKβ are necessary and sufficient for skeletal muscle atrophy. FASEB J 23:362-370
47. Durieux AC, Amirouche A, Banzet S, Koulmann N, Bonnefoy R, Pasdeloup M, Mouret C, Bigard X, Peinnequin A, Freyssenet D 2007 Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression. Endocrinology 148:3140-3147
48. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S 2002 A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99:9213-9218
49. Senf SM, Dodd SL, McClung JM, Judge AR 2008 Hsp70 overexpression inhibits NF-κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J 22:3836-3845
50. Murgia M, Serrano AL, Calabria E, Pallafacchina G, Lomo T, Schiaffino S 2000 Ras is involved in nerve-activity-dependent regulation of muscle genes. Nat Cell Biol 2:142-147
51. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD 2001 Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019
52. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, Bonconpagni S, Belia S, Wannenes F, Nicoletti C, Del Prete Z, Rosenthal N, Molinaro M, Protasi F, Fanò G, Sandri M, Musarò A 2008 Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8:425-436
53. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM 2006 PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103:16260-16265
54. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S, Sandri M 2007 FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6:458-471
55. Dubowitz V, Lane R, Sewry CA 2007 Muscle biopsy : a practical approach. 3rd ed. Philadelphia: Saunders Elsevier